about
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elPharmacological treatment and perceived health status during 1-year follow up in patients diagnosed with coronary artery disease, but ineligible for revascularization. Results from the Euro Heart Survey on Coronary RevascularizationSafety of coronary sirolimus-eluting stents in daily clinical practice: one-year follow-up of the e-Cypher registryClinical and angiographic acute and follow up results of intracoronary beta brachytherapy in saphenous vein bypass grafts: a subgroup analysis of the multicentre European registry of intraluminal coronary beta brachytherapy (RENO)Reperfusion treatment of ST-elevation acute myocardial infarctionDirect stenting versus direct stenting followed by centered beta-radiation with intravascular ultrasound-guided dosimetry and long-term anti-platelet treatment: results of a randomized trial: Beta-Radiation Investigation with Direct Stenting and GalTAXUS VI 2-year follow-up: randomized comparison of polymer-based paclitaxel-eluting with bare metal stents for treatment of long, complex lesionsGuidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of CardiologyStent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concernPercutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER StudyGuidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromesCardiac imaging in coronary artery disease: differing modalities.Angiographic and clinical one-year follow-up of the Cordis tantalum coil stent in a multicenter international study demonstrating improved restenosis rates when compared to pooled PTCA and BENESTENT-I data: the European Antiplatelet Stent InvestigatOne-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: a meta-analysis of individual patient data from randomized clinical trials.Let's talk BIG DATA.Evaluation of plaque characteristics in acute coronary syndromes: non-invasive assessment with multi-slice computed tomography and invasive evaluation with intravascular ultrasound radiofrequency data analysis.2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm AssociAngiographical follow-up after radioactive "Cold Ends" stent implantation: a multicenter trial.Detection of non-ST-elevation myocardial infarction and unstable angina in the acute setting: meta-analysis of diagnostic performance of multi-detector computed tomographic angiography.A novel bioresorbable polymer paclitaxel-eluting stent for the treatment of single and multivessel coronary disease: primary results of the COSTAR (Cobalt Chromium Stent With Antiproliferative for Restenosis) II study.Multidetector computed tomography angiography for assessment of in-stent restenosis: meta-analysis of diagnostic performance.Usefulness of proteinuria as a prognostic marker of mortality and cardiovascular events among patients undergoing percutaneous coronary intervention (data from the Evaluation of Oral Xemilofiban in Controlling Thrombotic Events [EXCITE] trial).[Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes].Relation of periprocedural bleeding complications and long-term outcome in patients undergoing percutaneous coronary revascularization (from the Evaluation of Oral Xemilofiban in Controlling Thrombotic Events [EXCITE] Trial).Head-to-head comparison of coronary plaque evaluation between multislice computed tomography and intravascular ultrasound radiofrequency data analysis.First-In-Man application of a miniature self-contained intracoronary magnetic resonance probe. A multi-centre safety and feasibility trial.Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention.Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries.Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis.Use of platelet glycoprotein IIb/IIIa inhibitors in diabetics undergoing PCI for non-ST-segment elevation acute coronary syndromes: impact of clinical status and procedural characteristics.Relationship between cardiovascular risk factors and biomarkers with necrotic core and atheroma size: a serial intravascular ultrasound radiofrequency data analysis.Universal definition of myocardial infarction.Guidelines on myocardial revascularization.Morphological analysis of atherosclerotic plaque retrieved by coronary atherectomy.Third universal definition of myocardial infarction.2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).A randomized, prospective, intercontinental evaluation of a bioresorbable polymer sirolimus-eluting coronary stent system: the CENTURY II (Clinical Evaluation of New Terumo Drug-Eluting Coronary Stent System in the Treatment of Patients with CoronarESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collabThe haemodynamic and myocardial effects of dopexamine: a new beta 2-adrenoceptor and dopaminergic agonist.Optical coherence tomography imaging during percutaneous coronary intervention impacts physician decision-making: ILUMIEN I study
P50
Q22242895-C14ADAD4-AC2D-486F-86D1-0471A0720E10Q28195632-05811E16-A60B-4B72-AA41-9ABC7A1F0A77Q28195674-905FC4CE-595D-47C9-A7D2-4C1818A6AEE1Q28196059-5D271D32-6E51-42BE-AF38-93420FD0DC0CQ28211419-BD599E7A-1D6E-4E6A-B71D-4F37D2E504D0Q28212611-78F1B912-D805-4277-85A7-132D790716B7Q28222747-19ED2E60-86B3-4C64-9396-1DD44F9A996AQ28239975-539A16A0-7FDE-414F-9A31-298749814E3EQ28291903-EDBDCAFA-AB38-44BF-96BC-07FE88ABE7C9Q28304018-8CEFECD0-11E4-40F6-BB9B-27A076E48814Q28306261-B76858CF-4225-4919-82FE-A489B8062757Q30493822-E91B1D95-4B5B-4DE7-989F-FAB76E92623CQ30627348-E47D7C97-155E-44D0-A509-0C9F6CB13D33Q30997981-A2BC0C7F-4D0E-4023-A372-06CE2E73D88AQ31137407-2EC49995-3521-44FB-8D2E-DEBFCB204814Q31169281-1EF56579-9B41-45D2-87B7-AC5FA85F010DQ33162947-9AC9D94C-6E61-4CD5-98B7-5A4256670891Q33183343-FA6C862F-E875-4B08-B5A5-441C07F0BC7DQ33311384-037FAE02-D9A7-416B-8AEA-29B0F04162F8Q33329008-87437AE8-A5F3-4815-9F56-D918156603D8Q33356758-A83760BA-F0FD-425F-AC13-4EF6659C9BF0Q33378384-3C165E86-30D6-4D0A-BC04-9E0F27ED763CQ33382210-DB59532E-5BD9-4610-8752-CA19F5A7CFDDQ33383917-26EECF08-E636-4284-B76B-4C8E9E7068F8Q33451103-3B35E915-5C0A-4A57-9C2A-8A5F4BB4073DQ33503479-B7877562-CEE8-4ABC-BA6E-A7900CC42654Q33613297-E1C7B172-40B9-4621-B936-B47896102EFAQ33788973-498A82CF-5C0A-4919-92C4-BBF76B195D68Q33791885-8B248CFF-862A-4FA0-8E26-F1E0D451F231Q33876187-56441E03-58CB-4E8F-8EB2-83815DEBA7E3Q33905460-9D389118-C307-4C0E-9830-7D93E1A98BDEQ34007701-6566384B-5C10-47E1-B6E8-0F30D17325F4Q34134730-DB3F32C1-6AA4-4128-BA87-D0B546501FBEQ34178492-2C23D235-F866-4D63-B69A-00FD8DB39FCDQ34295914-44B14ADB-ED11-47DD-BFA9-2A92A7A8EF01Q34351265-A70855E9-2BEA-4FCE-9F3A-8DC4139C1D89Q34354151-FCB22F37-C776-4D5E-92A8-EE87F0B739BEQ34368081-1D950E49-95BC-48CC-BD5C-9E4D096EB79EQ34447352-52B86925-7A17-4D8B-B9A1-549F56C46F10Q34488246-831FD666-AF6A-4B6E-B4E7-4015682A2AEA
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
William Wijns
@ast
William Wijns
@en
William Wijns
@es
William Wijns
@nl
type
label
William Wijns
@ast
William Wijns
@en
William Wijns
@es
William Wijns
@nl
prefLabel
William Wijns
@ast
William Wijns
@en
William Wijns
@es
William Wijns
@nl
P108
P1153
57205265704
7006420435
P21
P31
P496
0000-0002-7267-4376